Background The predictors of cardiac rupture (CR) in patients with acute myocardial infarction (AMI) treated with successful primary coronary angioplasty have not been identified.
n acute myocardial infarction (AMI), early recanalization of the culprit coronary artery is vital for the preservation of cardiac function and patient prognosis. 1,2 One method is direct percutaneous coronary intervention (PCI), now widely recognized as a useful and effective therapeutic strategy, and one associated with good outcomes for the patient. 3, 4 Although rare, cardiac rupture (CR) is a major adverse clinical consequence that is difficult to predict, and almost always fatal.
Current thinking suggests systemic inflammation is associated with ischemic heart diseases, including AMI. 5, 6 Previous studies have demonstrated that C-reactive protein (CRP), an acute phase representative protein, is associated with various complications in AMI, including cardiac events. 7, 8 It has been reported that the peak CRP concentration in plasma is an important predictor of CR, 9,10 but serum amyloid A protein (SAA) is also an important acute phase inflammatory protein that has an expanded dynamic range with different kinetics compared with CRP and is reported to be a more sensitive indicator of inflammation in some noncardiovascular conditions. 11 When in vivo inflammation occurs, synthesis of SAA, as well as CRP, in the liver is accelerated by inflammatory cytokines; that is, the kinetics of SAA are similar to those of CRP, but the clinical implication of the relationship between SAA and CR in AMI patients is unknown.
Methods

Patient Population
Between October 1999 and August 2005, 461 consecutive patients with AMI who were admitted to hospital within 24 h of onset were enrolled in the study. The study protocol, which included blood sampling for CRP and SAA, was approved by the hospital ethics committee, and informed consent was given by each patient and/or the family to 1 of the investigators before entry into the study. Diagnosis of AMI was based on: (1) complaint of chest pain; (2) electrocardiographic ST segment elevation of >0.1 mV in 2 or more limb leads, or >0.2 mV in 2 or more precordial leads, or presentation of left-bundle branch block; and (3) elevated peak-serum creatine kinase (CK) more than twice the upper limit of the patient's normal range. We excluded patients with renal failure on admission (serum CK >2.5 mg/dl), patients admitted >24 h after onset, patients who died <24 h after onset (ie, after blood samples had been taken) and patients who underwent drug-eluting stent implantation. Furthermore, to avoid other variables that could influence the serum levels of high-sensitivity CRP (hsCRP) or SAA, we excluded patients with a history of recent surgery or trauma within the preceding 2 months, malignancy or liver cirrhosis, acute or chronic inflammatory disease, or collagen disease. We had no patients with primary or secondary amyloidosis. In the end, 433 is the number of patients after exclusions. There were 224 cases of anterior myocardial infarction (MI).
Treatment Strategy
Following oral administration of 200 mg of aspirin and 200 mg of ticlopidine, all patients underwent direct PCI within 2 h of admission. For 72 h after reperfusion therapy, all patients were given intravenous nicorandil (96 mg/day) and heparin (10,000 units/day). We did not use abciximab.
Blood Sampling
On admission, blood samples were taken while patients were supine, for analysis of hsCRP, CK, and troponin-T. For 3 days after admission hsCRP was serially determined every 24 h, and CK every 4 h. At 24 h after onset, blood samples were taken, again while patients were supine, for analysis of brain natriuretic peptide (BNP), atrial natriuretic peptide (ANP), renin, aldosterone, epinephrine, norepinephrine, and SAA. The SAA assay by the latex agglutination nephelometric immunoassay was contracted out (BioMedical Laboratories Inc).
Hemodynamics and Cardiac Function
On admission, we used the Killip classification to assess the severity of the patient's condition. We also evaluated major complications, defined as ventricular arrhythmia (except reperfusion arrhythmia), pulmonary edema, cardiogenic shock, sub-acute thrombosis and cardiac death. We defined cardiogenic shock as systolic blood pressure <90 mmHg (without inotropic or intra-aortic balloon (IABP) support), signs of hypoperfusion (cold extremities, impaired mental status, or urine output <30 ml/h), and evidence of pulmonary congestion on chest X-ray.
All subjects, except 29 with cardiogenic shock, underwent left ventriculography soon after recanalization from a single plane with a right anterior deviation of 30°to evaluate left ventricular (LV) ejection fraction (EF), to calculate the LV end-diastolic volume index (LVEDVI) using the area-length method, and to evaluate regional wall motion (RWM), using the center-line method. 12 We excluded posterior infarctions from our evaluation because of the associated issues of inaccuracy. We also assessed LV enddiastolic pressure (LVEDP) at that time. We used the Thrombolysis in Myocardial Infarction (TIMI) classification to evaluate epicardial coronary flow.
Endpoints and Definitions
CR included free wall rupture (blow-out type, oozing type), ventricular septal perforation (VSP) and papillary muscle rupture. The diagnosis of free wall rupture was based on echocardiography followed by pericardiocentesis or surgical or postmortem examination. The blow-out type of rupture was defined as a free wall rupture with electromechanical dissociation, and sudden onset of severe hypotension without ECG change. The oozing type rupture was defined as a gradual bleeding into the pericardial sac, causing progressive or recurrent cardiac tamponade. VSP was diagnosed on the basis of abnormal shunt-flow at the interventricular septum on color Doppler echocardiography. Our follow-up period was 30 days after onset of AMI. The primary endpoint was CR or cardiac death.
Statistical Analysis
Values are expressed as mean ± standard-deviation. All statistical tests were 2-tailed, and a p-value <0.05 was considered statistically significant. The chosen cut-off points for the concentrations of the hsCRP at 24-h since onset, SAA, peak-CK, and BNP were based on the highest tertiles in the overall sample. Multivariate logistic regression analyses were performed, with the independent variables including age, gender, diabetes mellitus, culprit lesion location, the number of vessels involved, Killip classification on admission, ANP, BNP, peak-CK value, hsCRP at 24-h since onset, and SAA. The odds ratios and 95% confidence intervals (CI) were also calculated.
Results
A total of 433 patients with AMI were analyzed (291 male, 142 female; mean age 69±12 years). Before PCI therapy, simple aspiration thrombectomy catheters were used in 184 patients with massive visible thrombus, but distal protection devices were not used. Conventional plain old balloon angioplasty was sufficient in 85 patients, and the remaining 348 underwent coronary stenting. Of the total, 420 patients attained TIMI III grade flow, and the remaining 13 patients, TIMI II grade flow. Details of the 11 patients (2.5%) in whom CR occurred are summarized in Table 1 : free wall rupture occurred in 9 (6 patients were blow-out type, 3 patients were oozing type) and VSP in 2. None had PMR. Six patients died and 2 underwent surgery.
The characteristics of the 2 groups (with or without CR) are shown in Table 2 . There were no significant differences between them in terms of time elapsed from onset, or the existence of pre-infarction angina pectoris within 24 h of onset, or previous MI. Rates of female (64% vs 32%, p<0.05) and diabetes mellitus (64% vs 33%, p<0.05) were higher in the CR group and there was a tendency for patients with CR to be older, but it was not a significant trend. Table 3 is a comparison of the laboratory findings for the 2 groups. Plasma levels of peak-CK, hsCRP, and SAA were significantly higher in the CR group (peak-CK: 4,778±3,575 IU/L vs 2,461±2,661 IU/L, p<0.01; hsCRP: 6.91±5.15 mg/dl vs 3.32±3.87 mg/dl, p<0.01; SAA: 715± 502 g/dl vs 206±294 g/dl, p<0.0001). However, there were no significant differences in the plasma levels of BNP.
Hemodynamic data at the time of admission are shown in Table 4 . There were no significant differences between the 2 groups for heart rate, systolic blood pressure, Killip classification and culprit vessel location. There were significantly more patients with anterior infarction in the CR group (p<0.05) and significantly more frequent use of IABP (p<0.0001).
Major complication rates in the first 30 days are shown in Table 5 . There were significantly more patients with major complications, such as pulmonary edema (82% vs 13%, p<0.0001), cardiogenic shock (82% vs 11%, p<0.0001), and cardiac death (55% vs 5%, p<0.0001) in the group with CR. Table 6 shows LV function in the acute phase, soon after recanalization. There were no significant differences in LVEF, RWM, LVEDVI, or LVEDP.
The follow-up period was 30 days, during which CR occurred in 11 patients (2.5%). The predictors of CR by multivariate analysis in these AMI patients are shown in Table 7 . When the CR subjects were divided into 2 groups according to the threshold of the upper tertile (290 g/dl) of SAA, only 1 patient with CR was in the low SAA group. Multivariate analysis identified SAA concentration as an independent predictor of CR during 30 days (risk ratio: 8.8, 95% CI: 1.7-25.6, p=0.01).
Discussion
There are some patients with AMI who have a poor clinical course despite early recanalization therapy by PCI. There were some reports that CR occurs in 1-4% of cases of AMI, 9,13,14 but although rare, CR is a major adverse clinical consequence with a high mortality and is the second most common cause of in-hospital death, after pump failure. 15, 16 To date, however, it remains difficult to predict. In our study, there were no significant differences in terms of acute phase Killip classification or BNP concentration between subjects with or without CR. It is difficult to predict CR from the severity of either hemodynamics or heart failure on admission There are some reports that thrombolytic therapy increases the risk of CR, 14, 17, 18 which is why we did not use it. And yet, CR occurred in 2.5% of the study population, significantly more frequently in women than men. This confirmed previous data showing that the female gender is independently associated with adverse outcomes including CR after AMI. 19 The predisposition of female patients to CR is attributed to a susceptible collagen framework and differences in the collagen matrix within the infarcted myocardium. 20 Rupture occurs when transmural pressure exceeds the tensile strength of the heart's connective tissue substrate. Increased intramural pressure from bleeding within the reperfused AMI is a factor in rupture. Two types of collagen damage have been identified. 21 The first is loss of birefringence, observed in silver-impregnated sections. Degeneration of ground substance attached to collagen has been reported after myocardial ischemia. 22 The second type is loss of the collagen struts that form lateral connections between neighboring myocytes. 21 It has been reported that the peak-CRP concentration in plasma is an important predictor of CR in patients with AMI. 9, 10 Intramyocardial hemorrhage and pericarditis, resulting from slow leakage of blood into the pericardial space early after MI, can precipitate local cardiac inflammation, causing marked and persistent elevation of serum CRP. As for SAA, we reported that acute-phase plasma SAA concentrations after successful direct PCI are closely related to major adverse complications, including mortality. 23 However, the clinical implication of the relationship between inflammation and CR in AMI patients is unknown. The present study demonstrated a significant association between the SAA level in the acute phase of AMI and CR. Furthermore, the results also clarified that SAA is a predictor of CR.
It has been reported that the plasma SAA concentration is elevated from several hours to a few days after the onset of AMI, 24 and reaches its peak value approximately 24 h after onset. 24 We considered that the peak value of SAA was the most accurate indicator of the severity of AMI, which is why we took blood samples 24 h after onset.
The exact mechanism for the association between inflammation and future cardiovascular risk is not known. Laboratory studies have demonstrated that inflammation plays a pathophysiological role in atherogenesis and may promote the development of atherosclerotic plaques in coronary arteries. Acute-phase reactants may play a pathophysiological role in atherosclerotic plaque instability as manifested by elevated hsCRP levels in the presence of ruptured coronary artery plaques. Similar to hsCRP, SAA is synthesized in the liver in response to infection and inflammation and thus is also a representative inflammatory reactant. In AMI the inflammatory cytokine interleukin-6 and the acute-phase reactant SAA are produced at the site of coronary occlusion by macrophages and possibly vascular cells, whereas CRP is produced mainly in the liver and taken up locally by phagocytosing white blood cells. 25 During the acute-phase reaction, SAA is secreted as the predominant apolipoprotein on plasma high density lipoprotein (HDL)-cholesterol particles, where it was thought to be apolipoprotein A-1, and after HDL-mediated cholesterol delivery to cells. 26 These observations may explain its increased concentration in patients with acute coronary syndromes. Accordingly, SAA may be a more sensitive marker of disease severity and may represent a different type of acute-phase response than CRP.
There is 1 report that CRP is an excellent marker for plaque instability or post-stent inflammatory status, and that its source might be the inflamed site of the plaque or the coronary arterial wall injured by stenting. 27 Furthermore, coronary levels of SAA at the site of plaque rupture were increased relative to the systemic circulation, indicating local production of biologically active inflammatory mediators. In AMI, the acute-phase reactant SAA is produced at the site of coronary occlusion by macrophages and passively vascular cells. 24 To date, the exact mechanism of CR remains poorly understood. It can be precipitated by infarct expansion, which, in turn, is influenced by infarct healing and wall stress. 28 This complication usually occurs during the first week after a transmural infarction when the necrotic myocardium is vulnerable to wall stress. 28 During this period, pathological specimens show a central core of necrotic myocardium surrounded by a zone of hemorrhage and acute inflammation. 29 The degree of polymorphonuclear infiltration in the area of infarction could correlate with the incidence of CR. Severe inflammation resulting in tissue vulnerability is a possible cause of the extreme elevation in serum SAA level in patients with CR. In recent reports, predictors of CR were older age, female gender, anterior location, and thrombolysis. In the present study, however, these were not independent predictors by multivariate analysis.
Study Limitations
First, the small size of the sample population means that our results require confirmation in a large-scale trial before any concrete significance can be extrapolated. Second, we excluded from the study patients with renal failure, on the basis that they would not be able to tolerate coronary angioplasty. This may have introduced bias into our results. Third, the follow-up was short, at 30 days after onset, which does not allow for long-term prognosis. Fourth, both anterior and inferior MI were included in the evaluation of cardiac function. Fifth, the value of SAA was assayed only at a single time point. Therefore, the present study was not always satisfactory in either the number of patients or the observation period, and therefore, more patients will need to be accumulated in a future study that includes long-term prognosis.
